Duchesnay
Caring for mother and child during pregnancy
Diclectin
For the management of nausea and vomiting of pregnancy

Research Activities

As a Canadian research-based pharmaceutical company dedicated exclusively to the health and well-being of the pregnant woman and her unborn child, Duchesnay devotes 20% of its revenues to support research and education on drug therapies during pregnancy and breastfeeding.

Here are some of the research activities sponsored by Duchesnay:

  • Chaire Pharmaceutique Famille Louis Boivin: first and only pharmaceutical chair dedicated to research on medications during pregnancy and breastfeeding
  • First International Conference on Nausea and Vomiting of Pregnancy (NVP)
  • The Annual André Boivin Visiting Professorship in Maternal/Fetal Toxicology
  • Academic/Peer-to-peer education programs in reproductive health and safety
  • Various programmes in reproductive health and safety
  • International Women's Health Programs
  • Motherisk's Canada/USA Helpline on NVP
  • The Canadian Alliance for safe and effective medications during pregnancy and breastfeeding (www.casemed-pregnancy.org)

To know more about ongoing and published research projects, please click on the corresponding heading in the left column. All of Duchesnay's sponsorships are unrestricted and unconditional medical grants.

 
SOS Morning Sickness
 
SOS Morning Sickness
sosmorningsickness.org
This web site is entirely dedicated to nausea and vomiting of pregnancy
(NVP). >>>

Medical Information Service
1 888 666-0611
or contact us online

The health information contained herein is provided for general informational and educational purposes only and is not intended to replace discussions with a healthcare professional.

© 2000-2012, Duchesnay Inc., Canada Disclaimer and Terms of use